13F HOLDINGS REPORT
FINDELL CAPITAL MANAGEMENT LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0000921895-26-000470
Total Value
$347.8M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | LQDA | 2,851,449 | $98.3M | 28.28% |
| 2 | ESTABLISHMENT LABS HLDGS INC | ESTA | 1,130,460 | $82.4M | 23.69% |
| 3 | LIQUIDIA CORPORATION | LQDA | 1,200,000 | $41.4M | 11.90% |
| 4 | ROOT INC | ROOT | 235,000 | $17.0M | 4.88% |
| 5 | DAVE INC | 23834J201 | 70,000 | $15.5M | 4.46% |
| 6 | TURNING PT BRANDS INC | 90041L105 | 127,000 | $13.8M | 3.96% |
| 7 | OPORTUN FINL CORP | 68376D104 | 2,568,300 | $13.6M | 3.91% |
| 8 | SUPER GROUP SGHC LIMITED | SGHC | 940,000 | $11.2M | 3.23% |
| 9 | GEO GROUP INC NEW | GEO | 650,000 | $10.5M | 3.01% |
| 10 | CELSIUS HLDGS INC | CELH | 210,000 | $9.6M | 2.76% |
| 11 | EHEALTH INC | EHTH | 1,408,975 | $6.5M | 1.86% |
| 12 | ABIVAX SA | AAVXF | 48,000 | $6.5M | 1.86% |
| 13 | STRIDE INC | LRN | 90,000 | $5.8M | 1.68% |
| 14 | ADMA BIOLOGICS INC | ADMA | 300,000 | $5.5M | 1.57% |
| 15 | LIQUIDIA CORPORATION | LQDA | 156,000 | $5.4M | 1.55% |
| 16 | VOR BIOPHARMA INC | VOR | 231,000 | $3.0M | 0.87% |
| 17 | MINERALYS THERAPEUTICS INC | MLYS | 50,000 | $1.8M | 0.52% |